Vitamin D, calcium, OR combined supplementation for the primary prevention of fractures in community-dwelling adults evidence report and systematic review for the US Preventive Services Task Force

JAMA - Journal of the American Medical Association

Volumn 319, Issue 15, 2018, Pages 1600-1612

  Kahwati, Leila C ^a,b   Weber, Rachel Palmieri ^a   Pan, Huiling ^a,b   Gourlay, Margaret ^a,c   LeBlanc, Erin ^d   Coker Schwimmer, Manny ^a   Viswanathan, Meera ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D; VITAMIN;

ALL CAUSE MORTALITY; ARTICLE; CALCIUM INTAKE; CANCER INCIDENCE; CARDIOVASCULAR DISEASE; COMMUNITY LIVING; HIP FRACTURE; HUMAN; MALIGNANT NEOPLASM; MORTALITY RATE; NEPHROLITHIASIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ADULT; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; DIETARY SUPPLEMENT; FEMALE; FRACTURE; INDEPENDENT LIVING; MALE; PRIMARY PREVENTION;

ADULT; CALCIUM; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FEMALE; FRACTURES, BONE; HUMANS; INDEPENDENT LIVING; KIDNEY CALCULI; MALE; PRIMARY PREVENTION; VITAMIN D; VITAMINS;

EID: 85046073635     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.21640     Document Type: Article

References (42)

1. Ensrud KE. Epidemiology of fracture risk with advancing age. J Gerontol A Biol Sci Med Sci. 2013;68(10):1236-1242.
2. Office of the Surgeon General. Report of the Surgeon General's Workshopon Osteoporosis and Bone Health. Rockville, MD: Office of the Surgeon General (US); 2003.
3. Moyer VA; U. S. Preventive Services Task Force. Vitamin Dand calcium supplement ationtoprevent fractures in adults: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;158(9):691-696.
4. US Preventive Services Task Force. Section 3: topic work plan development in the US Preventive Services Task Force Procedure Manual. https://www.uspreventiveservicestaskforce.org/Page/Name/section-3-topic-work-plan-development. 2015. Accessed January 18, 2018.
5. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U. S. Preventive Services Task Force. Ann Intern Med. 2011;155(12):827-838.
6. United Nations Development Programme. Global launch of 2015 Human Development Report. http://hdr.undp.org. 2015. Accessed December 5, 2016.
7. Harris RP, Helfand M, Woolf SH, et al; Methods Work Group, ThirdUSPreventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3) (suppl):21-35.
8. US Preventive Services Task Force. Appendix VI: criteria for assessing internal validity of individual studies. https://www.uspreventiveservicestaskforce.org/Page/Name/appendix-vi-criteria-for-assessing-internal-validity-of-individual-studies. 2015. Accessed November 20, 2017.
9. Higgins JP, Altman DG, Gøtzsche PC, et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
10. West SL, Gartlehner G, Mansfield AJ, et al. Comparative Effectiveness Review Methods: Clinical Heterogeneity. Rockville, MD: Agency for Healthcare Research and Quality; 2010. AHRQ publication 10-EHC070-EF.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
12. Higgins JP, GreenS. Cochrane Handbook for Systematic Reviews of Interventions. http://handbook.cochrane.org. 2011. Accessed August 24, 2016.
13. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2014. AHRQ publication 10 (14)-EHC063-EF.
14. Komulainen MH, Kröger H, Tuppurainen MT, et al. HRT and vit D in prevention of non-vertebral fractures in postmenopausal women: a 5 year randomized trial. Maturitas. 1998;31(1):45-54.
15. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. VitaminD supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med. 1996;124(4):400-406.
16. 3 (cholecalciferol) supplementation on fractures and mortality in men and women living inthe community: randomised double blind controlled trial. BMJ. 2003;326(7387):469.
17. Scragg R, Stewart AW, Waayer D, et al. Effect of monthly high-dose vitaminD supplementation on cardiovascular disease in the Vitamin D Assessment Study: a randomized clinical trial. JAMA Cardiol. 2017;2(6):608-616.
18. Khaw K-T, Stewart AW, Waayer D, et al. Effect of monthly high-dose vitaminD supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial. Lancet Diabetes Endocrinol. 2017;5(6):438-447.
19. Recker RR, Hinders S, Davies KM, et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res. 1996;11(12):1961-1966.
20. Riggs BL, O'Fallon WM, MuhsJ, O'Connor MK, Kumar R, Melton LJ III. Long-term effects of calcium supplementationon serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res. 1998;13(2):168-174.
21. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. VitaminD and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586-1591.
22. Reid IR, Ames R, Mason B, et al. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med. 2008;168(20):2276-2282.
23. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementationon bone density inmen and women65 years of age or older. N EnglJ Med. 1997;337(10):670-676.
24. Jackson RD, LaCroix AZ, Gass M, et al; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669-683.
25. Lappe J, Watson P, Travers-Gustafson D, et al. Effect of vitamin D and calcium supplementation on cancer incidencein older women: a randomized clinical trial. JAMA. 2017;317(12):1234-1243.
26. Li M, Xia WB, Xing XP, et al. Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta. Chin Med J (Engl). 2011;124(19):3049-3053.
27. Wallace RB, Wactawski-Wende J, O'Sullivan MJ, et al. Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr. 2011;94(1):270-277.
28. Wactawski-Wende J, Kotchen JM, Anderson GL, et al; Women's Health Initiative Investigators. Calcium plus vitaminD supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354(7):684-696.
29. Prentice RL, Pettinger MB, Jackson RD, et al. Health risks and benefits from calcium and vitamin Dsupplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int. 2013;24(2):567-580.
30. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040.
31. Blondon M, Rodabough RJ, Budrys N, et al. The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism: from the Women's Health Initiative randomized controlled trial. Thromb Haemost. 2015;113(5):999-1009.
32. Donneyong MM, HornungCA, Taylor KC, et al. Risk of heart failure among postmenopausal women: asecondary analysis of the randomized trial of vitamin D plus calcium of the Women's Health Initiative. Circ Heart Fail. 2015;8(1):49-56.
33. 3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab. 1999;84(2):546-552.
34. Jackson RD, LaCroix AZ, Cauley JA, McGowan J. The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003;13(9) (suppl):S98-S106.
35. Tang JY, Fu T, Leblanc E, et al. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the Women's Health Initiative randomized controlled trial. J Clin Oncol. 2011;29(22):3078-3084.
36. Brunner RL, Wactawski-Wende J, Caan BJ, et al. The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer. 2011;63(6):827-841.
37. Bolland MJ, Grey A, Gamble GD, Reid IR. Calcium and vitaminD supplements and health outcomes: areanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr. 2011;94(4):1144-1149.
38. Chung M, Tang AM, Fu Z, Wang DD, Newberry SJ. Calcium intake and cardiovascular disease risk: an updated systematic review and meta-analysis. Ann Intern Med. 2016;165(12):856-866.
39. Reid IR, Bristow SM, Bolland MJ. Cardiovascular complications of calcium supplements. J Cell Biochem. 2015;116(4):494-501.
40. Avenell A, Mak JC, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014; (4): CD000227.
41. Bolland MJ, Grey A. A case study of discordant overlapping meta-analyses: vitamin D supplements and fracture. PLoS One. 2014;9(12):e115934.
42. Finkelstein JS. Calcium plus vitamin D for postmenopausal women-bone appétit?NEngl J Med. 2006;354(7):750-752.